Phone:
+1 877 302 8632
Fax:
+1 888 205 9894 (Toll-free)
E-Mail:
orders@antibodies-online.com

TAT antibody (AA 169-208)

This anti-TAT antibody is a Rabbit Polyclonal antibody detecting TAT in WB. Suitable for Human, Mouse and Rat.
Catalog No. ABIN5647931

Quick Overview for TAT antibody (AA 169-208) (ABIN5647931)

Target

See all TAT Antibodies
TAT (tyrosine Aminotransferase (TAT))

Reactivity

  • 14
  • 4
  • 3
  • 1
  • 1
  • 1
  • 1
  • 1
Human, Mouse, Rat

Host

  • 15
Rabbit

Clonality

  • 15
Polyclonal

Conjugate

  • 10
  • 1
  • 1
  • 1
  • 1
  • 1
This TAT antibody is un-conjugated

Application

  • 12
  • 12
  • 8
  • 7
  • 3
  • 2
  • 2
  • 2
  • 1
Western Blotting (WB)
  • Binding Specificity

    • 7
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    AA 169-208

    Purification

    Antigen affinity purified

    Immunogen

    Amino acids 169-208 (FSLYKTLAESMGIEVKLYNLLPEKSWEIDLKQLEYLIDEK-human) were used as the immunogen for the TAT antibody.

    Isotype

    IgG
  • Application Notes

    Optimal dilution of the TAT antibody should be determined by the researcher.\. Western blot: 0.5-1 μg/mL

    Restrictions

    For Research Use only
  • Buffer

    0.5 mg/mL if reconstituted with 0.2 mL sterile DI water

    Storage

    -20 °C

    Storage Comment

    After reconstitution, the TAT antibody can be stored for up to one month at 4°C. For long-term, aliquot and store at -20°C. Avoid repeated freezing and thawing.
  • Target

    TAT (tyrosine Aminotransferase (TAT))

    Alternative Name

    TAT / Tyrosine aminotransferase

    Background

    The nuclear gene TAT encodes the mitochondrial protein Tyrosine aminotransferase which is present in the liver and catalyzes the conversion of L-tyrosine into p-hydroxyphenylpyruvate. Mutations in this gene cause tyrosinemia (type II, Richner-Hanhart syndrome), a disorder accompanied by major skin and corneal lesions, with possible mental retardation. A regulator gene for tyrosine aminotransferase is X-linked.

    UniProt

    P17735

    Pathways

    Response to Water Deprivation
You are here:
Chat with us!